Alphabet-backed Oscar Health valued at $7.09 billion in lackluster debut
- Wall Street rises as big banks kick off earnings season
- JPMorgan (JPM) Reports a Q1 Beat on Revenue and Profit Fueled by Release of $5.2 Billion Reserved for Bad Loans; Shares Slightly Down
- Coinbase (COIN) direct listing IPO reference price set at $250
- Bernie Madoff, disgraced Ponzi schemer, dies at 82
- Goldman Sachs (GS) Q1 EPS Nearly Doubles Wall Street's View as Investment Banking Excels Amid SPAC and IPO Frenzy
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Reuters) - Shares of Oscar Health fell more than 7% in their stock market debut on Wednesday, fetching a valuation of just over $7 billion for the health insurance startup backed by Google parent Alphabet Inc.
The company's shares opened at $36 on the New York Stock Exchange, below its initial public offering (IPO) price of $39 per share. Oscar Health raised $1.2 billion from its offering of 31 million shares on Tuesday, after increasing the price range.
Oscar Health is yet to bring in a profit but saw its customers grow 75% in 2020 as more people sought remote healthcare during the COVID-19 pandemic, supercharging the telemedicine market and prompting companies to expand their scale.
It reported a net loss of $406.8 million in 2020, regulatory filings showed.
About 529,000 users strong, the New York-based company allows patients to schedule physician visits, check lab results, make emergency virtual appointments and refill prescriptions through its mobile app or online platform.
The company was worth $3.2 billion in a private fundraising round in 2018, according to PitchBook. Alphabet took a nearly 10% stake in Oscar Health for $375 million that year.
Oscar Health was founded in 2012 by Mario Schlosser, Kevin Nazemi, who is no longer a part of the company, and Josh Kushner, brother of former U.S. President Donald Trump's adviser and son-in-law, Jared Kushner.
The company's other investors include venture capital firm General Catalyst Group, Fidelity Investments parent FMR LLC, Peter Thiel's Founders Fund, investment firm Thrive Capital and Khosla Ventures.
Goldman Sachs & Co LLC, Morgan Stanley, Allen & Company LLC and Wells Fargo Securities are among lead underwriters for the offering.
(Reporting by Noor Zainab Hussain and Manojna Maddipatlain Bengaluru; Editing by Devika Syamnath)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan profits on capital markets in a cash-flush economy
- Goldman Sachs profit soars on global deals frenzy, trading boom
- Coinbase listing marks latest step in crypto's march to the mainstream
Create E-mail Alert Related CategoriesGeneral News, IPOs, Reuters
Related EntitiesGoldman Sachs, Donald J. Trump, Morgan Stanley, Clarium Capital Management, Fidelity Investments, Peter Thiel, Wells Fargo, IPO
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!